The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 5, 1999, Pages 1289-1296

  Wang, Junru ^a   Zheng, Huaien ^a   Sung, Ching Ching ^a   Hauer Jensen, Martin ^a  

^a UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

Experimental; Intestines; Pancreatic secretions; Radiation injuries; Somatostatin

Indexed keywords

OCTREOTIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GRANULOCYTE; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE MUCOSA; LEUKOCYTE MIGRATION; MALE; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; RADIATION INJURY; RAT;

ANIMALS; CELL MOVEMENT; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL AGENTS; GRANULOCYTES; INTESTINAL DISEASES; INTESTINAL MUCOSA; MALE; OCTREOTIDE; PEROXIDASE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032785169     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00293-X     Document Type: Article

References (51)

1. Berthrong M., Fajardo L.F. Radiation injury in surgical pathology Part II. Alimentary tract . Am J Surg Pathol. 5:1981;153-178.
2. Hauer-Jensen M. Late radiation injury of the small intestine Clinical, pathophysiologic, and radiobiologic aspects . Acta Oncol. 29:1990;401-415.
3. Hauer-Jensen M., Sauer T., Devik F., et al. Effects of dose fractionation on late roentgen radiation damage of rat small intestine. Acta Radiol Oncol. 22:1983;381-384.
4. Hauer-Jensen M., Sauer T., Berstad T., et al. Influence of pancreatic secretion on late radiation enteropathy in the rat. Acta Radiol Oncol. 24:1985;555-560.
5. Peck J.W., Gibbs F.A. Assay of premorbid murine jejunal fibrosis based on mechanical changes after X-irradiation and hyperthermia. Radiat Res. 112:1987;525-543.
6. Followill D.S., Kester D., Travis E.L. Histological changes in mouse colon after single- and split-dose irradiation. Radiat Res. 136:1993;280-288.
7. Morgenstern L., Hiatt N. Injurious effect of pancreatic secretions on postradiation enteropathy. Gastroenterology. 53:1967;923-929.
8. Mulholland M.V., Levitt S.H., Song C.W., et al. The role of luminal contents in radiation enteritis. Cancer. 54:1984;2396-2402.
9. Morgenstern L., Patin C.S., Krohn H.L., et al. Prolongation of survival in lethally irradiated dogs. Arch Surg. 101:1970;586-589.
10. Rachootin S., Shapiro S., Yamakawa T., et al. Potent anti-protease from Ascaris lumbricoides Efficacy in amelioration of post-radiation enteropathy (Abstr) . Gastroenterology. 62:1972;796.
11. Morris J.B., Guerrero N., Frankel W.L., et al. Octreotide pretreatment attenuates acute radiation enteritis. Surg Forum. 44:1993;150-152.
12. Hauer-Jensen M., Poulakos L., Osborne J.W. Effects of accelerated fractionation on radiation injury of the small intestine A new rat model . Int J Radiat Oncol Biol Phys. 14:1988;1205-1212.
13. Langberg C.W., Sauer T., Reitan J.B., et al. Tolerance of rat small intestine to localized single dose and fractionated irradiation. Acta Oncol. 31:1992;781-787.
14. Poulakos L., Hauer-Jensen M., Osborne J.W. Effects of accelerated fractionated irradiation on crypt cell kinetics of a localized segment of rat small intestine (Abstr). Radiat Res Soc. 36:1988;154.
15. Langberg C.W., Waldron J.A., Baker M.L., et al. Significance of overall treatment time for the development of radiation-induced intestinal complications An experimental study in the rat . Cancer. 73:1994;2663-2668.
16. Scott B.R., Langberg C.W., Hauer-Jensen M. Models for estimating the risk of ulcers in the small intestine after localized single or fractionated irradiation. Br J Radiol. 68:1995;49-57.
17. Richter K.K., Fagerhol M.K., Carr J.C., et al. Association of granulocyte transmigration with structural and cellular parameters of injury in experimental radiation enteropathy. Radiat Oncol Invest. 5:1997;275-282.
18. Richter K.K., Carr J.C., Sung C.-C., et al. Early granulocyte marker protein excretion is an independent predictor of late radiation enteropathy (Abstr). Radiat Res Soc. 45:1997;194.
19. Roseth A.G., Fagerhol M.K., Aadland E., et al. Assessment of the neutrophil dominating protein calprotectin in feces A methodologic study . Scand J Gastroenterol. 27:1992;793-798.
20. Roseth A.G., Kristinsson J., Fagerhol M.K., et al. Faecal calprotectin A novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol. 28:1993;1073-1076.
21. Hauer-Jensen M., Sauer T., Devik F., et al. Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol Oncol. 22:1983;299-303.
22. Langberg C.W., Sauer T., Reitan J.B., et al. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol. 35:1996;81-87.
23. Baddeley A.J., Gundersen H.J.G., Cruz-Orive L.M. Estimation of surface area from vertical sections. J Microsc. 142:1986;259-276.
24. Richter K.K., Langberg C.W., Sung C.-C., et al. Increased transforming growth factor β (TGF-β) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int J Radiat Oncol Biol Phys. 39:1997;187-195.
25. Harris A.G. Somatostatin and somatostatin analogues Pharmacokinetics and pharmacodynamic effects . Gut. 35:(Suppl. 3):1994;S1-S4.
26. Guan D., Maouyo D., Sarfati P., et al. Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats. Endocrinology. 127:1990;298-304.
27. Lamberts S.W.J., van der Lely A.J., de Herder W.W., et al. Octreotide. N Engl J Med. 334:1996;246-254.
28. Weckbecker G., Liu R., Tolcsvai L., et al. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res. 52:1992;4973-4978.
29. Weckbecker G., Tolcsvai L., Liu R., et al. Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995). Metabolism Clin Exp. 41:(Suppl. 2):1992;99-103.
30. Patel P.C., Barrie R., Hill N., et al. Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis. Surgery. 116:1994;1148-1152.
31. Wadler S., Benson A.B., Engelking C., et al. Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol. 16:1998;3169-3178.
32. Ippoliti C. Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients. Am J Health Syst Pharm. 55:1998;1573-1580.
33. Nordesjo-Haglund G., Lonnqvist B., Lindberg G., et al. Octreotide for nausea and vomiting after chemotherapy and stem-cell transplantation. Lancet. 353:1999;846.
34. Bourne R.B., Kearsley J.H., Grove W.D., et al. The relationship between early and late gastrointestinal complication of radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 9:1983;1445-1450.
35. Peters L.J., Ang K.K., Thames H.D. Accelerated fractionation in the radiation treatment of head and neck cancer. Acta Oncol. 27:1988;185-194.
36. Wang C.-J., Leung S.W., Chen H.-C., et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma Evidence suggestive of consequential late effect (CQLE) . Int J Radiat Oncol Biol Phys. 40:1998;85-91.
37. Trott K.R., Breiter N., Spiethoff A. Experimental studies on the pathogenesis of the chronic radiation ulcer of the large bowel in rats. Int J Radiat Oncol Biol Phys. 12:1986;1637-1643.
38. Krause P., Ziegler K. Experimentelle Untersuchungen ueber die Einwirkung der Roentgenstrahlen auf tierische Gewebe. A. Uebersicht ueber die in der Litteratur niedergelegten Angaben ueber die Wirkung der Roentgenstrahlen auf innere Organe. Fortschr a d Geb d Roentgenstr. 10:1906;126-182.
39. Hiatt N., Warner N.E. Influence of intestinal content on radiation lesions of the small intestine. Proc Soc Exp Biol Med. 124:1967;937-939.
40. Sokol A.B., Lipson L.W., Morgenstern L., et al. Protection against lethal irradiation injury by pancreatic enzyme exclusion. Surg Forum. 18:1967;387-389.
41. Quastler H. The nature of intestinal radiation death. Radiat Res. 4:1956;303-320.
42. Smyth R.L., van Velzen D., Smyth A.R., et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 343:1994;85-86.
43. Lloyd-Still J.D., Uhing M.R., Arango V., et al. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat. J Pediatr Gastroenterol Nutr. 26:1998;489-495.
44. Kimura R.E., Arango V., Lloyd-Still J. Indomethacin and pancreatic enzymes synergistically damage intestine of rats. Dig Dis Sci. 43:1998;2322-2332.
45. Becciolini A., Fabbrica D., Cremonini D., et al. Quantitative changes in the goblet cells of the rat small intestine after irradiation. Acta Radiol Oncol. 24:1985;291-299.
46. Walker R.I., Ledney G.D., Galley C.B. Aseptic endotoxemia in radiation injury and graft-vs-host disease. Radiat Res. 62:1975;242-249.
47. Kanwar S., Wallace J.L., Befus D., et al. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol. 266:1994;G222-G229.
48. Graham M.F., Diegelmann R.F., Elson C.O., et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology. 94:1988;257-265.
49. Graham M.F., Drucker D.E.M., Diegelmann R.F., et al. Collagen synthesis by human intestinal smooth muscle cells in culture. Gastroenterology. 92:1987;400-405.
50. Dery O., Corvera C.U., Steinhoff M., et al. Proteinase-activated receptors Novel mechanisms of signaling by serine proteases . Am J Physiol. 274:1998;C1429-C1452.
51. d'Andrea M.R., Derian C.K., Leturcq D., et al. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem. 46:1998;157-164.